United Kingdom · Series A startup

Who invested in Convergence Pharmaceuticals

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$35Mraised across 1 round since 2010, from 1 source

Latest round
Series A, $35MOct 2010
Investors
4
See who backed them

The rounds

  1. Oct 2010

The exit

ExitBuyerPriceWhen
AcquiredBiogen Idec$675MJan 2015

From historical deal records. Wrong? Tell us.

Everyone who backed them

SV Life SciencesVC firm1round
SV Health InvestorsVC firm1round
Apposite CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Convergence Pharmaceuticals

Who invested in Convergence Pharmaceuticals?

Convergence Pharmaceuticals's investors include SV Life Sciences, New Leaf Venture Partners, SV Health Investors and Apposite Capital.

How much has Convergence Pharmaceuticals raised?

Convergence Pharmaceuticals has raised $35M across 1 round since 2010.

When did Convergence Pharmaceuticals last raise?

Convergence Pharmaceuticals's most recent round was a Series A of $35M in Oct 2010.

What was Convergence Pharmaceuticals's biggest round?

Its most recent round, $35M in Oct 2010, is also its largest on record.

Who backed Convergence Pharmaceuticals first?

Convergence Pharmaceuticals's first round on record, in Oct 2010, was backed by SV Life Sciences, New Leaf Venture Partners and SV Health Investors and 1 others.

What stage is Convergence Pharmaceuticals at?

Convergence Pharmaceuticals's latest named round is a Series A, in Oct 2010.

Where is Convergence Pharmaceuticals based?

Convergence Pharmaceuticals is based in the United Kingdom.

Companies like Convergence Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.